World
How 23andMe Went From $6B Valuation to Penny Stock | WSJ What Went Wrong
DNA-testing company 23AndMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests to homes with just a tube of spit. But challenges with its business model and continued data privacy concerns for consumers have brought the company once valued at $6 billion to a valuation of nearly $0, with Nasdaq threatening to delist it. WSJ explains what went wrong with Wojcicki’s biotech business. 0:00 Home DNA testing 0:49 The rise of 23andMe 2:18 The turning point 4:03 23andMe’s fall 5:23 What’s next? What Went Wrong explores the challenging conditions and decisions that led to a company s downturn. #23andMe #DNA #WSJ :::: Visit my YouTube channel @ The Wall Street Journal ( [ 🔗 Click ‼️ ]] )
( 100 Page ) :: 🏠 94 95 96 97 98 99 100 ▶️ ⭕️
🌟 10
Don’t Buy the RTX 4060! (These are Better)
🌟 4
Can you buy the White House?
🌟 6
Canning Green Chili Peppers like you buy from the store!
🌟 4
I'm sorry, Sports CS nominee Kipchumba Murkomen to Kenyans [ Jul / 27 / 2024 ]
🌟 7
Nhạc Remix Tik Tok 🎧 ~ Những Bản Nhạc Remix Giúp Bạn Thư Giãn Trên Tik Tok VN #19 🎶🎧